Femasys (NASDAQ:FEMY) Stock Price Down 14.6% – Here’s Why

Femasys Inc. (NASDAQ:FEMY) shares were down 14.6% during mid-day trading on Thursday . The stock traded as low as $3.04 and last traded at $3.05. 43,437 shares were traded during trading, an increase of 38% from the average daily volume of 31,380 shares. The stock had previously closed at $3.57.

Analysts Set New Price Targets

A number of research firms have recently weighed in on FEMY. Weiss Ratings lowered Femasys from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday. Wall Street Zen raised shares of Femasys to a “hold” rating in a research note on Saturday, June 13th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Femasys presently has a consensus rating of “Moderate Buy” and an average price target of $106.67.

Femasys Stock Performance

The company has a 50-day simple moving average of $5.42 and a two-hundred day simple moving average of $8.63. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.98 and a current ratio of 3.91. The firm has a market capitalization of $9.09 million, a P/E ratio of -0.56 and a beta of -2.13.

Femasys (NASDAQ:FEMY) last posted its quarterly earnings data on Friday, May 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.33) by $1.43. Femasys had a negative return on equity of 258.08% and a negative net margin of 521.97%.The business had revenue of $0.42 million during the quarter, compared to the consensus estimate of $0.77 million.

Institutional Trading of Femasys

A number of hedge funds have recently bought and sold shares of the company. Jane Street Group LLC bought a new stake in Femasys during the second quarter valued at about $82,000. Osaic Holdings Inc. bought a new position in shares of Femasys in the second quarter worth about $45,000. Geode Capital Management LLC lifted its position in shares of Femasys by 50.8% during the 4th quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock valued at $224,000 after buying an additional 131,052 shares in the last quarter. Kovack Advisors Inc. purchased a new position in shares of Femasys during the 4th quarter valued at about $27,000. Finally, Banco BTG Pactual S.A. bought a new position in shares of Femasys during the 4th quarter valued at approximately $88,000. Hedge funds and other institutional investors own 65.27% of the company’s stock.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.